Stock Scorecard
Stock Summary for Kiniksa Pharmaceuticals International plc. - Class A (KNSA) - $38.54 as of 11/5/2025 12:37:55 PM EST
Total Score
13 out of 30
Safety Score
46 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for KNSA
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for KNSA
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for KNSA
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for KNSA
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for KNSA (46 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 5 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 2 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for KNSA
Financial Details for KNSA
Company Overview |
|
|---|---|
| Ticker | KNSA |
| Company Name | Kiniksa Pharmaceuticals International plc. - Class A |
| Country | USA |
| Description | N/A |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 11/4/2025 |
Stock Price History |
|
| Last Day Price | 38.54 |
| Price 4 Years Ago | 11.77 |
| Last Day Price Updated | 11/5/2025 12:37:55 PM EST |
| Last Day Volume | 687,203 |
| Average Daily Volume | 511,988 |
| 52-Week High | 42.05 |
| 52-Week Low | 17.82 |
| Last Price to 52 Week Low | 116.27% |
Valuation Measures |
|
| Trailing PE | 82.24 |
| Industry PE | 72.03 |
| Sector PE | 78.24 |
| 5-Year Average PE | 26.76 |
| Free Cash Flow Ratio | 9.96 |
| Industry Free Cash Flow Ratio | 12.42 |
| Sector Free Cash Flow Ratio | 28.54 |
| Current Ratio Most Recent Quarter | 3.85 |
| Total Cash Per Share | 3.87 |
| Book Value Per Share Most Recent Quarter | 7.10 |
| Price to Book Ratio | 5.61 |
| Industry Price to Book Ratio | 11.41 |
| Sector Price to Book Ratio | 33.29 |
| Price to Sales Ratio Twelve Trailing Months | 4.69 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.68 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.92 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 45,161,000 |
| Market Capitalization | 1,740,504,940 |
| Institutional Ownership | 90.05% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 550.00% |
| Annual Earnings Growth | -406.68% |
| Reported EPS 12 Trailing Months | 0.45 |
| Reported EPS Past Year | 0.57 |
| Reported EPS Prior Year | -0.61 |
| Net Income Twelve Trailing Months | 35,918,000 |
| Net Income Past Year | -43,193,000 |
| Net Income Prior Year | 14,084,000 |
| Quarterly Revenue Growth YOY | 61.20% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | 13.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 174,858,000 |
| Total Cash Past Year | 183,581,000 |
| Total Cash Prior Year | 107,954,000 |
| Net Cash Position Most Recent Quarter | 174,858,000 |
| Net Cash Position Past Year | 183,581,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 438,436,000 |
| Total Stockholder Equity Prior Year | 438,839,000 |
| Total Stockholder Equity Most Recent Quarter | 535,383,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 101,733,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.25 |
| Free Cash Flow Past Year | 25,412,000 |
| Free Cash Flow Prior Year | 13,171,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.36 |
| MACD Signal | 0.70 |
| 20-Day Bollinger Lower Band | 25.83 |
| 20-Day Bollinger Middle Band | 33.86 |
| 20-Day Bollinger Upper Band | 41.89 |
| Beta | 0.16 |
| RSI | 44.55 |
| 50-Day SMA | 26.81 |
| 150-Day SMA | 20.91 |
| 200-Day SMA | 18.52 |
System |
|
| Modified | 11/4/2025 2:44:13 AM EST |